The sympathomimetic amine clobenzorex acts on the ventrolateral nucleus of the hypothalamus, increasing the release of norepinephrine and dopamine in synaptic spaces and decreasing their absorption in presynaptic nerve endings, leading to a rise in norepinephrine concentrations. and dopamine. Norepinephrine essentially curbs appetite by activating alpha 4 and beta 1 receptors in the hypothalamus nuclei. There are three main ways that medicines aid in weight loss and body fat reduction:

a) A decrease in food consumption.

b) Specific metabolic alterations.

A surge in energy use.

The peak concentration of Clobenzorex, which ranges in concentration from 8 to 47 ng/ml, is reached 50 to 120 minutes after the initial dose. The digestive system efficiently absorbs clobenzorex. Para-hydroxyclobenzorex is removed by the kidneys.